首页> 外文期刊>Nature >Vaccine-induced CD8~+ T cells control AIDS virus replication
【24h】

Vaccine-induced CD8~+ T cells control AIDS virus replication

机译:疫苗诱导的CD8〜+ T细胞控制艾滋病病毒复制

获取原文
获取原文并翻译 | 示例
       

摘要

Developing a vaccine for human immunodeficiency virus (HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus. Most of these elite controllers express the histocompatibility alkies HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus, yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control6, with three Mamu-B*08-restricted CD8+ T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8~+ T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8~+ T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8~+ T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8~+ T-cell responses can control replication of the AIDS virus.%表达Mamu-B*08分子(它与人白细胞抗原Classrn1分子HLA-B*27具有重要的结构相似性)的印度rn恒河猴对高致病性SIVmac239病毒有一定的控rn制能力。这个系统为携带艾滋病病毒(HIV)的rn人能够对该病毒有极好控制的罕见病例提供了rn一个模型。在这项研究中,Davla Watkins及其rn同事发现,由疫苗诱导产生的、被引导仅仅抵rn抗与Mamu-B*08结合的三个免疫显性T-细胞rn表位(Vif RL8、Vif RL9和Nef RL10)的CD8+Trn细胞,能够控制Mamu-B*
机译:全面了解一些艾滋病毒感染者控制该病毒复制的罕见情况,可能有助于开发针对人类免疫缺陷病毒(HIV)的疫苗。这些精英控制器中的大多数表示组织相容性烷基HLA-B * 57或HLA-B * 27(参考文献3)。到目前为止,这些等位基因与低浓度的血浆病毒仍然是最牢固的关联,但是这些个体中的控制机制尚不完全清楚。在这里,我们为表达Mamu-B * 08(这是HLA-B * 27介导的精英对照6的动物模型)的印度恒河猴接种了三个Mamu-B * 08限制性CD8 + T细胞表位,并证明了这些接种过的动物对高致病性克隆猿猴免疫缺陷病毒(SIV)mac239病毒的复制。血液,淋巴结和结肠中针对这些Vif和Nef表位的CD8〜+ T细胞的高频率与病毒控制有关。而且,针对Nef RL10表位(Nef氨基酸137-146)的CD8 + T细胞应答的频率与急性期病毒血症的减少显着相关。最后,八种疫苗中的两种在慢性期失去了对病毒复制的控制,并伴随着所有三个靶向表位的逃逸,进一步将这三种CD8 + T细胞反应牵连到病毒复制的控制中。我们的发现表明,狭窄靶向疫苗诱导的病毒特异性CD8〜+ T细胞反应可以控制AIDS病毒的复制。%表达Mamu-B * 08分子(它与人白细胞抗原Classrn1分子HLA-B * 27具有重要意义的结构相似性)的印度rn恒河猴对高致病性SIVmac239病毒有一定的控rn制能力。出了一个模型。在此研究中,Davla Watkins及其rn同事发现,由疫苗诱导产生的,被引导单一抵抗rn抗与Mamu-B * 08结合的三个免疫显性T-细胞rn表位(Vif RL8,Vif RL9和Nef RL10)的CD8 + Trn细胞,能够控制Mamu-B *

著录项

  • 来源
    《Nature》 |2012年第7422期|p.129-133a5|共6页
  • 作者单位

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA,Medical Scientist Training Program, University of Wisconsin-Madison, Madison, Wisconsin 53705, USA;

    Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA;

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02129, USA;

    Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02129, USA;

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Department of Microbiology, University of Minnesota, Minneapolis, Minnesota 55455, USA;

    Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02129, USA;

    Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02129, USA;

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Departmentof Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA;

    Laboratorio de Biologia Molecular de Flavivirus, Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro, Brazil;

    Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA,Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA;

    Laboratorio de Biologia Molecular de Flavivirus, Instituto Oswaldo Cruz-FIOCRUZ, Rio de Janeiro, Brazil;

    Instituto de Tecnologia em Imunobiologicos, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil;

    Department of Biostatistics, Section on Statistical Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA;

    AIDS and Cancer Virus Program, SAIC Frederick, Inc., National Cancer Institute, Frederick, Maryland 21702, USA;

    Department of Microbiology, University of Minnesota, Minneapolis, Minnesota 55455, USA;

    AIDS and Cancer Virus Program, SAIC Frederick, Inc., National Cancer Institute, Frederick, Maryland 21702, USA;

    Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts 02129, USA;

    Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:54:17

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号